Ramy Behman, MD, PhD

Assistant Professor
University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Assistant Professor in the Department of Colon and Rectal Surgery at The University of Texas MD Anderson Cancer Center, with research focused on optimizing colorectal cancer care through clinical epidemiology, ctDNA-enabled trial design, and outcomes/health-services research.

Presentation(s):

• PPS16. Risk of Ovarian Metastasis in Colorectal Cancer-Related Carcinomatosis

  Thursday, March 5, 2026
  10:00 AM - 10:30 AM MST

• PPS8. Advanced clinical T category and high tumor grade independently predict worse survival among rectal cancer patients undergoing organ preservation

  Thursday, March 5, 2026
  10:00 AM - 10:30 AM MST

• P45. The management of mucosal melanoma: a population-based analysis of treatment patterns and outcomes

  Thursday, March 5, 2026
  2:53 PM - 3:00 PM MST

• TIP3. A prospective feasibility study using preoperative ctDNA to tailor neoadjuvant chemotherapy for patients with colorectal or appendiceal adenocarcinoma

  Friday, March 6, 2026
  3:55 PM - 3:59 PM MST

• TIP6. Metronidazole to optimize the microbiome of patients with rectal adenocarcinoma undergoing neoadjuvant therapy: protocol for the phase II MONARCH trial

  Friday, March 6, 2026
  3:51 PM - 3:55 PM MST

• Colorectal Great Debates

  Friday, March 6, 2026
  4:15 PM - 5:15 PM MST